Scarica l'app Stockscreener
0.8445
0.52%
0.0044
Dopo l'orario di chiusura:
.83
-0.0145
-1.72%
Precedente Chiudi:
$0.8401
Aprire:
$0.829
Volume 24 ore:
895.71K
Relative Volume:
0.14
Capitalizzazione di mercato:
$27.61M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-4.231
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
-4.02%
1M Prestazione:
+75.86%
6M Prestazione:
-5.11%
1 anno Prestazione:
-38.38%
Intervallo 1D:
$0.8181
$0.89
Intervallo di 1 settimana:
$0.8181
$1.06
Portata 52W:
$0.38
$1.59
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Confronta PMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
0.8445 | 27.46M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Leading vs lagging indicators on ProMIS Neurosciences Inc. performanceSafe and Scalable Return Strategy Blueprint - Newser
What is ProMIS Neurosciences Inc. company’s growth strategyLow Risk Forecasts For Smart Trading - jammulinksnews.com
ProMIS Neurosciences Inc. Charts Flash Early Recovery SignalsCapital Preserving Trade Plan Templates Shared - metal.it
Will a bounce in ProMIS Neurosciences Inc. offer an exitPredictive Model for Intraday Swing Forecast - Newser
Should I buy ProMIS Neurosciences Inc. stock before earningsDaily Investment Ideas with Market Insight - Newser
What earnings revisions data tells us about ProMIS Neurosciences Inc.Daily Market Movers Screener with Filters - Newser
Earnings visualization tools for ProMIS Neurosciences Inc.Daily Pick Forecast with Entry Zones - Newser
How to build a custom watchlist for ProMIS Neurosciences Inc.Steady Return Plan Based on Data Analysis - Newser
ProMIS Neurosciences to Showcase Protein-Misfolding Drug - GlobeNewswire
What makes ProMIS Neurosciences Inc. stock price move sharplyFree Trade Timing Strategy With Technical Data - Newser
Can swing trading help recover from ProMIS Neurosciences Inc. lossesFree Trade Timing Strategy With Technical Data - Newser
ProMIS Neurosciences Inc. Uptrend in Early Stages Indicators Say YesVerified Signal From Chart Patterns Detected - metal.it
Published on: 2025-07-29 18:58:10 - metal.it
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference - GlobeNewswire
Is ProMIS Neurosciences Inc. stock poised for growthAI Screener Based Stock Summary Report - Newser
ProMIS Neurosciences Inc. stock momentum explainedSafe and Scalable Return Strategy Blueprint - Newser
Sectors Driving Future Growth for ProMIS Neurosciences Inc. StockSwing Trade Entry and Exit Point Analysis - Newser
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the… - Informazione.it
ProMIS Neurosciences Announces Private Placement Financing - GlobeNewswire
When is ProMIS Neurosciences Inc. stock expected to show significant growthPre Market Entry Points To Watch Now - jammulinksnews.com
Will ProMIS Neurosciences Inc. Hold Gains Into CloseStock Market Watch With Alerts Shows Unusual Activity - metal.it
Is it the right time to buy ProMIS Neurosciences Inc. stockExplosive earnings growth - jammulinksnews.com
ProMIS Neurosciences Inc (PMN) Stock: A Year of Highs and Lows in the Market - investchronicle.com
ProMIS Neurosciences raises $12 million through PIPE financing and warrants - Investing.com Australia
Intrinsic Value of ProMIS Neurosciences Inc. Stock: Is It Undervalued or OvervaluedPrice Forecast Based on AI Analysis - Newser
Building trade automation scripts for ProMIS Neurosciences Inc.Predictive Analytics for Equity Growth Potential - Newser
What is the risk reward ratio of investing in ProMIS Neurosciences Inc. stockAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Clinical-Stage Biotech ProMIS Raises $12M to Advance Novel Alzheimer's Treatment PMN310 - Stock Titan
Multi factor analysis applied to ProMIS Neurosciences Inc.Chart Risk Profile for Capital Preservation - Newser
What earnings revisions data tells us about ProMIS Neurosciences Inc. Free Buy Low Sell High Stock Watch - Newser
How strong is ProMIS Neurosciences Inc. company’s balance sheetMaximize gains with strategic stock entries - jammulinksnews.com
How Efficient Is ProMIS Neurosciences Inc. at Controlling Operating CostsSafe and Smart Investment Picks - Newser
How many analysts rate ProMIS Neurosciences Inc. as a “Buy”Get timely market insights for better trades - jammulinksnews.com
What drives ProMIS Neurosciences Inc. stock priceMassive portfolio appreciation - PrintWeekIndia
Analysts Are Bullish on Top Healthcare Stocks: ProMIS Neurosciences (PMN), Bruker (BRKR) - The Globe and Mail
ProMIS Neurosciences Alights on Path to Novel Alzheimer’s Treatment - StocksToTrade
Is ProMIS Neurosciences Inc. stock a growth or value playFree Predictions - jammulinksnews.com
ProMIS Neurosciences Inc. Stock Analysis and ForecastExplosive earnings growth - Autocar Professional
What analysts say about ProMIS Neurosciences Inc. stockAccelerated earnings growth - PrintWeekIndia
When is the best time to buy ProMIS Neurosciences Inc. stockHigh-impact stock picks - jammulinksnews.com
Will ProMIS Neurosciences Inc. stock split in the near futureConsistent triple-digit returns - jammulinksnews.com
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):